PMC:7335631 / 1933-2139
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T20 | 128-136 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T12 | 140-144 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 175-183 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T11 | 92-96 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 128-136 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 33-113 | Sentence | denotes | So, such variability would help the scientists towards the drug development [1]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32640274-18452964-44882418 | 29-30 | 18452964 | denotes | 6 |
32640274-32576227-44882419 | 110-111 | 32576227 | denotes | 1 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T45 | 92-96 | CHEBI:23888;CHEBI:23888;GO:0017144 | denotes | drug |
T46 | 97-108 | GO:0017144 | denotes | development |
T47 | 140-149 | SP_7 | denotes | SARS-CoV2 |
T48 | 161-169 | GO:0031975 | denotes | envelope |
T49 | 175-183 | GO:0016020 | denotes | membrane |
T50 | 191-203 | GO:0019013 | denotes | nucleocapsid |
T97 | 50-58 | GO:0031975 | denotes | ity woul |
T98 | 70-79 | SP_10 | denotes | cientists |
T99 | 84-93 | SP_7 | denotes | rds the d |
T100 | 119-125 | SO:0000417 | denotes | vario |
T101 | 133-142 | PG_2 | denotes | ins of SA |
T102 | 155-164 | SP_7 | denotes | e(S), env |